Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice

Cancer Research

Volumn 65, Issue 18, 2005, Pages 8548-8557

  Conaway, C Clifford ^a   Wang, Chung Xiou ^a   Pittman, Brian ^a   Yang, Yang Ming ^b   Schwartz, Joel E ^a,c   Tian, Defa ^d   McIntee, Edward J ^e   Hecht, Stephen S ^e   Chung, Fung Lung ^a,d  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETYLCYSTEINE; BENZO[A]PYRENE; CARCINOGEN; CASPASE 3; CYCLINE; PHENETHYL ISOTHIOCYANATE; PHENETHYL ISOTHIOCYANATE N ACETYLCYSTEINE; SULFORAPHANE; SULFORAPHANE N ACETYLCYSTEINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIETARY INTAKE; FEEDING; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CARCINOGENESIS; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SMOKING; TOBACCO;

ACETYLCYSTEINE; ADENOCARCINOMA; ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; BENZO(A)PYRENE; BODY WEIGHT; CARCINOGENS; CASPASE 3; CASPASES; CELL GROWTH PROCESSES; DISEASE PROGRESSION; FEMALE; IN SITU NICK-END LABELING; ISOTHIOCYANATES; LUNG NEOPLASMS; MICE; MICE, INBRED A; NITROSAMINES; SMOKING; THIOCYANATES;

EID: 24944480252     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0237     Document Type: Article

References (65)

1. U.S. Mortality public use data tapes 1960-2000. U.S. Mortality Volumes 1930-1959. National Center for Health Statistics, Centers for Disease Control and Prevention, 2003.
2. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-8.
3. Higgins IT, Wynder EL. Reduction in risk of lung cancer among ex-smokers with particular reference to histologic type. Cancer 1988;62:2397-401.
4. Becher H, Jockel KH, Timm J, Wichman HE, Drescher K. Smoking cessation and nonsmoking intervals: effect of different smoking patterns on lung cancer risk. Cancer Causes Control 1991;2:381-7.
5. Burns DM. Cigarette smoking among the elderly: disease consequences and the benefits of cessation. Am J Health Promot 2000;14:357-61.
6. National Cancer Institute. Report of the Lung Cancer Progress Review Group, NIH Publication number 01-5025, Bethesda: August 2001. p. 1-52.
7. O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002;8:314-46.
8. Kelley MJ, McCorty DC. Prevention of lung cancer: summary of published evidence. Chest 2003;123:50-9S.
9. Yang CS, Yang GY, Landau JM, Kim S, Liao J. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp Lung Res 1998;24:629-39.
10. Pereira MA, Li Y, Gunning WT, et al. Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 2002;23:1185-92.
11. Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, Wattenberg LW. Effect of chemopreventive agents on separate stages of progression of benzo[α]pyrene induced lung tumors in A/J mice. Carcinogenesis 2004;25:197-201.
12. Kim DJ, Takasuka N, Nishino H, Tsuda H. Chemoprevention of lung cancer by lycopene. Biofactors 2000;13:95-102.
13. Fenwick GR, Heaney RK, Mullin WJ. Glucosinolates and their breakdown products in food and food plants. Crit Rev Food Sci Nutr 1983;18:12-201.
14. Jiao D, Ho CT, Foiles P, Chung FL. Identification and quantification of the N-acetylcysteine conjugate of allyl isothiocyanate in human urine after ingestion of mustard. Cancer Epidemiol Biomarkers Prev 1992;1:383-8.
15. Conaway CC, Krzeminski J, Amin S, Chung FL. Decomposition rates of isothiocyanate conjugates determine the activity as inhibitors of cytochrome P450 isozymes. Chem Res Toxicol 2001;14:1170-6.
16. Wattenberg LW. Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J Natl Cancer Inst 1977;58:395-8.
17. Hecht SS. Chemoprevention of isothiocyanates. J Cell Biochem Suppl 1995;22:195-209.
18. Lin JM, Amin S, Trushin N, Hecht SS. Effects of isothiocyanates on tumorigenesis by benzo[a]pyrene in murine tumor models. Cancer Lett 1993;74:151-9.
19. Chung FL. Chemoprevention of lung cancer by isothiocyanates and their conjugates in A/J mouse. Exp Lung Res 2001;27:319-30.
20. Izzotti A, Balansky RM, Dagostini F, et al. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res 2001;61:2472-9.
21. Yang YM, Conaway CC, Chiao JW, et al. Inhibition of benzo(a)pyrene- induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the post-initiation phase is associated with activation of MAP kinases and p53 activity and induction of apoptosis. Cancer Res 2002;62:2-7.
22. Guo Z, Smith TJ, Wang E, et al. Effects of phenethyl istohiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 1992;13:2205-10.
23. Yang CS, Smith TJ, Hong JY. Cytochrome P-450 enzymes as targets for Chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res 1994;54:1982-6s.
24. Zhang Y, Talalay P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 1994;54:1976-81s.
25. Conaway CC, Yang YM, Chung FL. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002;3:233-55.
26. Chung FL, Kelloff G, Steele V, et al. Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. Cancer Res 1996;56:772-8.
27. Chung FL, Conaway CC, Rao CV, Reddy BS. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 2000;21:2287-91.
28. Yu R, Mandlekar S, Harvey KJ, Ucker DS, Kong ANT. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 1998;58:402-8.
29. Huang C, Ma W, Li J, Hecht SS, Dong Z. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res 1998;58:4102-6.
30. Gamet-Payrastre L, Li P, Lumeau L, et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000;60:1426-33.
31. Xu K, Thornalley PJ. Signal transducting activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br J Cancer 2001;84:670-3.
32. Xiao D, Singh SV. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 2002;62:3615-9.
33. Chiao JW, Chung FL, Kancherla R, et al. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 2002;20:631-6.
34. London SJ, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 2000;356:724-9.
35. Spitz MR, Duphorne CM, Detry MA, et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:1017-20.
36. Zhao B, Seow A, Lee EJ, et al. Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 2001;10:1063-7.
37. Fowke JH, Chung FL, Jin F, et al. Urinary isothiocyanate levels, Brassica, and human breast cancer. Cancer Res 2003;63:3980-6.
38. Lin HJ, Probst-Hensch NM, Louie AD, et al. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998;7:647-52.
39. Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colon cancer risk in the Singapore Chinese Health Study. Carcinogenesis 2003;23:2055-61.
40. Pitot HC, Dragon YP. Chemical Carcinogenesis, Chap. 8. In: Klaassen CD. editor. Casarett & Doull's Toxicology: the Basic Science of Poisons, 6th ed. New York: McGraw-Hill; 2001. p. 241-319.
41. Foley JF, Anderson MW, Stoner GD, Gaul BW, Hardisty JF, Maronpot RR. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp Lung Res 1991;17:157-68.
42. Belinsky SA, Devereux TR, Foley JF, Maronpot RR, Anderson MW. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res 1992;52:3163-73.
43. Belinsky SA, Stefanski SA, Anderson MW. The A/J mouse lung as a model for developing new chemo-intervention strategies. Cancer Res 1993;53:410-6.
44. Hecht SS, Isaacs S, Trushin N. Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone and benzo[iz]pyrene: a potentially useful model for evaluation of chemopreventive agents. Carcinogenesis 1994;15:2721-5.
45. Schmid H, Karrer P. Synthese der racemischen und der optisch aktiven formen des sulforphans. Helv Chim Acta 1948;31:1497-505.
46. Schenk WA, Durr M. Enantioselective organic syntheses using chiral transition metal complexes. Part 3. Synthesis of (R)-sulforaphane using [CpRu((R,R)-CHIRAPHOS)]+ as chiral auxiliary. Chem Eur J 1997;3:713-16.
47. Whitesell JK, Wong MS. Asymmetric synthesis of chiral sulfinate esters and sulfoxides. Synthesis of sulforaphane. J Org Chem 1994:59:597-601.
48. Kassahun K, Davis M, Hu P, Martin B, Baillei T. Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem Res Toxicol 1997;10:1228-33.
49. Eklind KI, Morse MA, Chung FL. Distribution and metabolism of the natural anticarcinogen phenethyl isothiocyanate in A/J mice. Carcinogenesis 1990;11:2033-6.
50. Hecht SS, Chen DB, Dong M, Ornaf RM, Hoffmann D, Tso TC. Chemical studies on tobacco smoke. LI: Studies on non-volatile nitrosamines in tobacco. Beitr Tabakforsh 1977;9:1-9.
51. Haedicke W, Popper HH, Buck CR, Zatloukal K. Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner. Biotechniques 2003;35:164-8.
52. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1991;119:493-501.
53. Schwartz JL, Muscat JE, Baker V, et al. Oral cytology assessment by flow cytometry of DNA adducts, aneuploidy, proliferation and apoptosis shows differences between smokers and non-smokers. Oral Oncol 842-54.
54. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37.
55. Hochberg Y, Tamhane AC. Multiple comparisons procedures. New York: John Wiley & Sons; 1987. p. 3-5.
56. Dunnett CW. A multiple comparisons procedure for comparing several treatments with a control. J Am Stat Assoc 1955;50:1096-121.
57. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1978:53:457-81.
58. Peto R, Peto J. Asymptomatically efficient rank invariant procedure. J R Stat Soc 1972;135A:185-207.
59. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons; 1986. p. 220-40.
60. Hoffman D, Hecht SS. Advances in tobacco carcinogenesis. In: Cooper CS, Grover PL, editors. Handbook of experimental pharmacology, vol. 94/I. Heidelberg, Germany: Springer-Verlag; 1990. p. 63-102.
61. Myzak MC, Karplus PA, Chung FL, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004;64:5767-74.
62. Jackson SJT, Singletary KW. Sulforphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 2004;25:219-27.
63. Hu R, Kim BR, Chen C, Hebbar V, Kong AN. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003;24:1361-7.
64. Pullar JM, Thomson SJ, King MJ, Turnbull CI, Midwinter RG, Hampton MB. The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis. Carcinogenesis 2004:25:765-72.
65. Yang Y-M, Jhanwar-Uniyal M, Schwartz J, et al. N-acetylcysteine conjugate of phenethyl isothiocyanate enhances apoptosis in growth-stimulated human lung cells. Cancer Res 2005;65:8538-47.